# InVitria

the global leader in chemically-defined animal-origin-free recombinant proteins for biologics manufacturing, with an ISO 9001:2015-certified cGMP facility; its rice-based ExpressTec platform is the first plant-based recombinant expression system to support an FDA-, EMA-, and PMDA-approved injectable biologic;…

Source: https://en.bioecon.ru/companies/invitria/
Updated: 2026-08-15

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | InVitria has received non-dilutive NIH/NIAID SBIR grants (e.g., $725,000 in 2009 and $1,500,000 in 2012) rather than priced venture rounds. | https://biobase.whitefordresearch.com/companies/invitria |
| Funding | No funding disclosed. [medium confidence] | https://prospeo.io/c/invitria-revenue |
| Certification | ISO 9001:2015 certified for the manufacture of purified and partially purified products of recombinant proteins extracted from transgenic plants. | https://invitria.com/, https://invitria.com/about-invitria/, https://invitria.com/resources/cgmp-statement/, https://invitria.com/resources/iso-90012015-certificate-of-registration/ |
| Production site | 2718 Industrial Drive, Junction City, Kansas 66441, USA. | https://invitria.com/, https://invitria.com/about-invitria/, https://invitria.com/resources/iso-90012015-certificate-of-registration/ |
| Production site | Fulfillment facility in Rotterdam, the Netherlands (opened October 2024). | https://invitria.com/about-invitria/ |
| Revenue | Estimates vary significantly across sources, ranging from $4.2 million to $53 million annually. [medium confidence] | https://invitria.com/about-invitria/, https://prospeo.io/c/invitria-revenue, https://www.datanyze.com/companies/invitria/127206351 |

Independent sources: biobase.whitefordresearch.com, datanyze.com, prospeo.io

## Technologies

- [Recombinant human serum albumin (rHSA)](https://en.bioecon.ru/technology/recombinant-human-serum-albumin/)